KX
Insider selling
Konstantinos Xynos sold $71K of Replimune Group, Inc. (REPL) stock
Konstantinos Xynos, Chief Medical Officer of Replimune Group, Inc. (REPL), sold 14,023 shares of REPL stock worth $71K, per an SEC Form 4 filed May 20, 2026.
It was an open-market sale.
The trade happened on May 18, 2026, 2 days before it was made public.
REPL has moved +156.9% since the trade date, from $5.01 to $12.87 (Sep 21, 2026 close).
- Traded
- May 18, 2026
- Disclosed
- May 20, 2026
- Filing delay
- 2 days
- Price since
- +156.9%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More REPL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.